Crossmark

Bayesian approaches in drug development: continuing the virtuous cycle

Crossref DOI link: https://doi.org/10.1038/s41573-024-01052-w

Published Online: 2024-10-10

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Igl, Wilmar https://orcid.org/0000-0001-9490-4585
Constant, John
License Information

Text and Data Mining valid from 2024-10-10

Version of Record valid from 2024-10-10
More Information

Article History

First Online: 10 October 2024

Competing interests

: The authors are both employees of ICON PLC; however, they are not aware of any competing interests.